ZENTECH
0094
XDL
5156
MERIDIAN
5040
TWL
7079
PGB
0091
MY Stock MarketDetailed Quotes
6068 PCCS
- 0.335
- 0.0000.00%
15min DelayNoon Break Dec 26 09:07 CST
73.90MMarket Cap15.95P/E (TTM)
0.335High0.335Low37.60KVolume0.335Open0.335Pre Close12.60KTurnover0.54552wk High0.08%Turnover Ratio220.59MShares0.14052wk Low0.021EPS TTM16.03MFloat Cap3.311Historical High11.55P/E (Static)47.86MShs Float0.135Historical Low0.029EPS LYR0.00%Amplitude0.01Dividend TTM0.47P/B100Lot Size2.99%Div YieldTTM
PCCS Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 35.95%115.1M | 76.60%172.67M | -18.47%377.85M | -10.21%110.34M | 26.61%85.07M | -18.64%84.67M | -42.25%97.77M | 11.44%463.43M | 4.49%122.88M | -30.00%67.19M |
| Cost of revenue | 33.70%97.69M | 77.10%144.21M | -21.37%303.91M | -19.23%81.79M | 25.09%67.62M | -18.00%73.07M | -42.69%81.43M | 11.30%386.53M | 6.54%101.27M | -33.76%54.06M |
| Gross profit | 50.14%17.41M | 74.14%28.46M | -3.86%73.93M | 32.07%28.55M | 32.90%17.45M | -22.48%11.6M | -39.92%16.34M | 12.15%76.9M | -4.14%21.62M | -8.62%13.13M |
| Operating expense | 60.82%27.42M | 8.99%19.23M | 5.32%71.57M | 11.96%20.47M | -18.55%16.41M | 13.70%17.05M | -9.41%17.65M | 8.21%67.95M | 5.96%18.28M | 30.83%20.14M |
| Selling and administrative expenses | 60.82%27.42M | 8.99%19.23M | 6.48%72.72M | 16.10%21.62M | -18.55%16.41M | 13.70%17.05M | -9.41%17.65M | 7.51%68.29M | 3.55%18.62M | 30.83%20.14M |
| -Selling and marketing expense | 40.38%1.64M | 34.40%1.93M | -18.51%9.82M | -297.50%-3.34M | -6.14%4.12M | -72.78%1.17M | -65.79%1.44M | 2.18%12.05M | 3.44%-841K | 12.70%4.39M |
| -General and administrative expense | 62.32%25.78M | 6.74%17.3M | 11.84%62.9M | 28.26%24.96M | -22.01%12.28M | 48.41%15.88M | 6.07%16.21M | 8.72%56.25M | 3.23%19.46M | 36.98%15.75M |
| Total other operating income | ---- | ---- | 239.64%1.15M | ---- | ---- | ---- | ---- | -53.57%338K | ---- | ---- |
| Operating profit | -83.52%-10.01M | 807.52%9.23M | -73.61%2.36M | 142.31%8.08M | 114.81%1.04M | -14,640.54%-5.45M | -116.89%-1.3M | 54.91%8.95M | -37.04%3.34M | -581.17%-7.02M |
| Net non-operating interest income (expenses) | -59.95%-1.2M | -141.53%-2.75M | -5.61%-4.28M | 12.68%-1.18M | -6.27%-1.2M | -59.70%-749K | -4.40%-1.14M | -53.20%-4.05M | -46.28%-1.36M | -95.34%-1.13M |
| Non-operating interest income | -53.55%144K | -9.52%190K | 42.91%1.08M | 38.72%412K | -45.15%147K | 129.63%310K | 281.82%210K | 534.45%755K | 1,137.50%297K | 892.59%268K |
| Non-operating interest expense | 26.72%1.34M | 118.01%2.94M | 11.47%5.36M | -3.45%1.6M | -3.57%1.35M | 75.33%1.06M | 17.71%1.35M | 73.93%4.8M | 73.82%1.65M | 130.81%1.4M |
| Net investment income | 69.53%6.28M | 140.55%3.7M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -0.54%183K | 57.26%184K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -315.18%-2.38M | -137.76%-573K | ||||||||
| Less:Other special charges | ---- | ---- | 97.68%-31K | ---- | ---- | ---- | ---- | ---1.34M | ---- | ---- |
| Less:Write off | ---- | ---- | 26.05%2.41M | ---- | ---- | ---- | ---- | 693.36%1.91M | ---- | ---- |
| Other non-operating income (expenses) | -87.42%335K | -71.30%1.28M | 22.45%2.48M | 59.56%-4.92M | -62.03%284K | -59.43%2.66M | -62.37%4.45M | -8.63%2.02M | -1,448.92%-12.16M | 175.00%748K |
| Income before tax | -207.12%-10.87M | 286.97%7.75M | -54.65%4.64M | 188.25%6.06M | 101.61%119K | -158.44%-3.54M | -89.14%2M | 51.36%10.24M | -237.34%-6.87M | -453.14%-7.4M |
| Income tax | -187.93%-510K | 148.94%1.77M | -71.26%837K | 560.61%872K | -701.82%-1.32M | -33.56%580K | -57.97%709K | 82.00%2.91M | 178.11%132K | -61.06%220K |
| Net income | -151.50%-10.36M | 362.60%5.99M | -71.48%3.81M | 1,018.10%5.19M | 118.93%1.44M | -179.46%-4.12M | -91.55%1.29M | 9,114.19%13.34M | -55.77%464K | -122.64%-7.62M |
| Net income continuous operations | -151.50%-10.36M | 362.60%5.99M | -48.04%3.81M | 174.12%5.19M | 118.93%1.44M | -179.46%-4.12M | -92.28%1.29M | 41.86%7.32M | -235.40%-7M | -300.47%-7.62M |
| Net income discontinuous operations | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 213.33%6.02M | 281.14%7.46M | --0 |
| Noncontrolling interests | 47.53%-329K | -7.96%-339K | 12.10%-2.63M | -72.64%-1.41M | 75.96%-282K | -33.69%-627K | 41.31%-314K | 1.84%-2.99M | -61.07%-815K | -18.13%-1.17M |
| Net income attributable to the company | -187.23%-10.03M | 293.35%6.33M | -60.60%6.44M | 415.64%6.6M | 126.75%1.73M | -161.78%-3.49M | -89.85%1.61M | 463.21%16.33M | -17.75%1.28M | -165.35%-6.45M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -187.23%-10.03M | 293.35%6.33M | -60.60%6.44M | 415.64%6.6M | 126.75%1.73M | -161.78%-3.49M | -89.85%1.61M | 463.21%16.33M | -17.75%1.28M | -165.35%-6.45M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -186.62%-0.045 | 294.44%0.0284 | -61.34%0.0288 | 456.60%0.0295 | 126.01%0.0077 | -159.70%-0.0157 | -90.24%0.0072 | 451.85%0.0745 | -26.39%0.0053 | -157.39%-0.0296 |
| Diluted earnings per share | -186.62%-0.045 | 294.44%0.0284 | -61.34%0.0288 | 456.60%0.0295 | 125.93%0.0077 | -159.92%-0.0157 | -90.20%0.0072 | 451.85%0.0745 | -26.39%0.0053 | -158.26%-0.0297 |
| Dividend per share | 0 | 0.01 | 0.01 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.